Eterna Therapeutics
ERNA
#9826
Rank
NZ$10.14 M
Marketcap
$1.88
Share price
4.67%
Change (1 day)
-6.45%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of November 2024 : -0.7108

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 37.4065.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.29-422.58%๐Ÿ‡บ๐Ÿ‡ธ USA
8.38-1,278.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-2.05 188.56%๐Ÿ‡บ๐Ÿ‡ธ USA
1.65-331.55%๐Ÿ‡ซ๐Ÿ‡ท France
5.83-920.81%๐Ÿ‡บ๐Ÿ‡ธ USA
3.09-534.83%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.02-524.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel